Faculty Opinions recommendation of Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature（2023）
关键词
pembrolizumab,iic melanoma,adjuvant therapy,metastasis-free
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要